***c63-amg (2012), Black, Chrome, Mint Condition & Low Mileage; Rare Find*** on 2040-cars

Auto blog

Mercedes-Benz USA considering moving south

Mercedes-Benz may be a German automaker first and foremost, but it's a global operation. Among its many offices around the world, the company employs some 800 staffers at its US headquarters in New Jersey. But that office could be moving down South in the near future. According to reports in the Atlanta Business Chronicle, the Wall Street Journal and Automotive News, Mercedes is looking into relocating its American head office from Montvale, NJ, where it's been based since 1972, to one of several locations under consideration below the Mason-Dixon line. Among the front-runners is Atlanta, where Porsche bases its North American operations. The presence of a trained workforce, necessary infrastructure, compliant officials and proximity to a major hub for international air traffic could make the Georgian metropolis an attractive proposition for Mercedes. Several locations in North Carolina are also said to be under consideration, as well. Either way, MBUSA's relocation to the South would put it closer to its assembly plant in Tuscaloosa, AL, and to the Port of Brunswick near Savannah from which it ships out those vehicles made in Alabama to points overseas. The relocation project is reportedly being handled by commercial real-estate firm JLL Inc, which is helping Toyota handle its relocation from southern California and Ohio to Texas. Sources don't expect, however, for New Jersey to let Mercedes go without a fight. The state's Grow NJ Assistance Program could offer MBUSA an attractive incentives package to stay in Montvale. The company previously planned in 1998 to relocate to Pearl River, NY, but ultimately ended up staying in Jersey. News Source: Atlanta Business Chronicle, Wall Street Journal via Automotive News - sub. req. Mercedes-Benz north carolina mbusa

Daimler boss says fuel cell vehicles will be disappointing for at least 10 years

Daimler AG CEO Dieter Zetsche is pretty confident about the imminence of self-driving cars. Hydrogen fuel-cell vehicles? Not so much. He didn't even get into the possibility of self-driving fuel-cell vehicles, but we're okay taking future technologies one at a time. Zetsche, in an interview from the Detroit Auto Show last week, said the automotive industry is about a decade away from avoiding disappointing experiences with production fuel-cell vehicles, In Auto News says. Zetsche was quick to note that the Mercedes-Benz parent entered into a fuel-cell partnership with Ford and Nissan early last year in an effort to split costs and speed things along, with the expectation that the group would develop something together by 2017, but even that won't be able to smooth things out fully. Toyota and Hyundai have said they'd have their own production vehicles on the road sooner than that. Multi-corporation-partnerships notwithstanding, Zetsche bemoaned the high costs, lack of vehicle volume and minimal refueling infrastructure as the proverbial roadblocks to more rapid development and adoption of fuel-cell vehicles. As it is, the US has just 10 publicly accessible hydrogen refueling stations, eight of which are in Southern California, according to the US Department of Energy. As for autonomous automobiles, Zetsche was more upbeat. Daimler already has what it calls the "Distronic" cruise control system that includes an automatic braking feature and has successfully driven a car 60 miles with "with relatively modest adjustments to the existing onboard technology." Featured Gallery Mercedes-Benz F-Cell View 9 Photos News Source: In Auto News Green Mercedes-Benz Hydrogen Cars

Britain orders 10,000 ventilators from F1/McLaren/Mercedes/Ford/Rolls-Royce/Airbus

Paramedics and ambulance personnel get instructions from a command unit outside London's ExCel Centre arena, which is being turned into a 4,000 bed temporary hospital called NHS Nightingale to deal with coronavirus patients. The hospital is due to open Monday, March 30. / AP     LONDON — Britain has ordered 10,000 ventilators from a consortium of leading aerospace, engineering and Formula One racing companies which will start production this week in response to an urgent government call for industry to help save lives. The 27-strong team, including Airbus, BAE Systems, Ford and Rolls-Royce, have joined forces to ramp up production of a ventilator made by Smiths Group, which supports those with complications from COVID-19. The consortium, which also includes seven Formula One teams including McLaren and Mercedes, home to World Champion Lewis Hamilton, said they had pulled staff off existing projects to meet the national need. Some 1,228 people have died from coronavirus in the United Kingdom and a senior health official said on Saturday the country would be doing well if it manages to keep the death toll below 20,000. "This consortium brings together some of the most innovative companies in the world," Dick Elsy, the head of the consortium, said in a statement. "I am confident this consortium has the skills and tools to make a difference and save lives." The United Kingdom, which initially only had 5,000 ventilators available in its National Health Service, has been trying to secure additional supplies after realising it needed 30,000 to cope with the peak of the outbreak. Prime Minister Boris Johnson, who is now in isolation in Downing Street after testing positive for coronavirus, made an emergency appeal earlier this month for manufacturers to retool their production lines and start making specialist health equipment including ventilators. Britain now has about 8,000 ventilators, with another 8,000 on order from international manufacturers that are due in coming weeks. Last week it placed an order for a newly-designed model from the vacuum cleaner company Dyson that will need to be approved by the health regulator. Mercedes part of a separate effort, too Separately on Monday a second consortium including Mercedes Formula One and other F1 teams said it had developed in less than a week a new version of a breathing aid that can help coronavirus patients.